# VITASPRING BIOMEDICAL CO. LTD.

VITASPRING BIOMEDICAL CO. LTD. is a public company listed on OTC as VSBC, headquartered in Riverside, CA, United States.

## Company overview

- **Legal name:** VITASPRING BIOMEDICAL CO. LTD.
- **Former names in filing history:** Shemn Corp. (2017-03-06 to 2020-04-27)
- **Classification:** Public company
- **Industry (SIC):** 8731 — Services-Commercial Physical & Biological Research
- **Headquarters:** Riverside, CA, United States
- **Incorporated in:** NV
- **Fiscal year end:** January 31
- **Ticker:** OTC: VSBC
- **SEC CIK:** 0001697884

## About

VITASPRING BIOMEDICAL CO. LTD. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001697884, and its reported industry is Services-Commercial Physical & Biological Research. In 10-K filed on 2026-06-17, it reported annual revenue of USD 0; net income of USD -415,368; total assets of USD 14,676 for the fiscal period ended 2026-01-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.

## Financials

Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.

### FY2026 (period ended 2026-01-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$415,368 (USD -415,368)
- **Total assets:** $14,676 (USD 14,676)
- **Operating cash flow:** -$2,688 (USD -2,688)

### FY2025 (period ended 2025-01-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$774,922 (USD -774,922)
- **Total assets:** $14,378 (USD 14,378)
- **Cash and equivalents:** $0 (USD 0)
- **Operating cash flow:** -$14,675 (USD -14,675)
- **Later filings:** Cash and equivalents: shown as originally filed; later filings report different values for the same periods.

### FY2024 (period ended 2024-01-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$1.1M (USD -1,118,562)
- **Total assets:** $137,342 (USD 137,342)
- **Operating cash flow:** -$34,920 (USD -34,920)

### FY2023 (period ended 2023-01-31)

- **Revenue:** $0 (USD 0)
- **Net income:** -$4.2M (USD -4,164,396)
- **Total assets:** $765,948 (USD 765,948)
- **Operating cash flow:** -$77,556 (USD -77,556)

## Recent SEC filings

- Form 10-Q — filed 2026-09-17 — period 2026-07-31 — FORM 10-Q
- Form 8-K — filed 2026-09-10 — period 2026-09-07 — FORM 8-K
- Form 10-K — filed 2026-06-17 — period 2026-01-31 — FORM 10-K
- Form 10-Q — filed 2026-06-17 — period 2026-04-30 — FORM 10-Q
- Form 10-Q — filed 2026-06-17 — period 2025-10-31 — FORM 10-Q
- Form 10-Q — filed 2026-06-17 — period 2025-07-31 — FORM 10-Q
- Form 10-Q — filed 2026-06-15 — period 2025-04-30 — FORM 10-Q
- Form 10-K — filed 2026-06-08 — period 2025-01-31 — FORM 10-K
- Form 10-Q — filed 2026-05-06 — period 2024-10-31 — FORM 10-Q
- Form 10-Q — filed 2026-04-22 — period 2024-07-31 — FORM 10-Q
- Form 10-Q — filed 2026-04-02 — period 2024-04-30 — FORM 10-Q
- Form 10-K — filed 2026-03-12 — period 2024-01-31 — FORM 10-K

---

Updated: 2026-10-23T06:52:41Z

Canonical page: https://altss.com/profile/vitaspring-biomedical-co-ltd

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology